Literature DB >> 21150894

Therapeutic transplantation of the distal gut microbiota.

A Khoruts1, M J Sadowsky.   

Abstract

Although it is generally accepted that the distal gut microbiota are relatively stable in healthy adult individuals, a collapse of the microbial community structure resulting from antibiotic therapy or pathogen presence can lead to gut dysfunction. However, recent findings demonstrate that it is possible to engraft new microbiota from a donor source, resulting in the restoration of gut functionality and improvement in health. This builds upon decades of case reports and series in which fecal transfers were used to successfully treat refractory and recurrent Clostridium difficile infection. As fecal transplantation becomes part of mainstream medicine, it will likely provide a unique opportunity to study the interactions of humans with their attendant microbiota and allow greater insights into their synergistic functionality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150894     DOI: 10.1038/mi.2010.79

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  32 in total

Review 1.  Treatment of refractory and recurrent Clostridium difficile infection.

Authors:  Christina M Surawicz; Jacob Alexander
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-19       Impact factor: 46.802

2.  A rendezvous with our microbes.

Authors:  Jeffrey I Gordon; Todd R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-15       Impact factor: 11.205

Review 3.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

Review 4.  Intestinal commensal microbes as immune modulators.

Authors:  Ivaylo I Ivanov; Kenya Honda
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

5.  Fecal microbiota transplant for Clostridium difficile infection in older adults.

Authors:  William M Tauxe; John P Haydek; Paulina A Rebolledo; Emma Neish; Kira L Newman; Angela Ward; Tanvi Dhere; Colleen S Kraft
Journal:  Therap Adv Gastroenterol       Date:  2015-12-31       Impact factor: 4.409

Review 6.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

7.  Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice.

Authors:  T Hudcovic; J Kolinska; J Klepetar; R Stepankova; T Rezanka; D Srutkova; M Schwarzer; V Erban; Z Du; J M Wells; T Hrncir; H Tlaskalova-Hogenova; H Kozakova
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 8.  Contributions of intestinal bacteria to nutrition and metabolism in the critically ill.

Authors:  Michael J Morowitz; Erica M Carlisle; John C Alverdy
Journal:  Surg Clin North Am       Date:  2011-08       Impact factor: 2.741

9.  Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Authors:  Susana Fuentes; Els van Nood; Sebastian Tims; Ineke Heikamp-de Jong; Cajo J F ter Braak; Josbert J Keller; Erwin G Zoetendal; Willem M de Vos
Journal:  ISME J       Date:  2014-02-27       Impact factor: 10.302

10.  Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.

Authors:  Pehga F Johnston; Dale N Gerding; Katherine L Knight
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.